Virtual agents: The future of pharma education, engagement and insights
Virtual agents: The future of pharma education, engagement and insights This exclusive whitepaper dives into the cutting-edge applications of virtual […]
Virtual agents: The future of pharma education, engagement and insights This exclusive whitepaper dives into the cutting-edge applications of virtual […]
Join us for an eye-opening conversation with Eric Solomon, Practice Leader for Paid Media activation at AI-industry innovator at Real
Given common questions of fact and law raised in complaints brought throughout the federal court system, the Paraquat lawsuits have
By Ayako Wakatsuki Pedersen, Ph.D., Senior Vice President of Translational Research at IO Biotech The tumor microenvironment (TME) is one
HFA152a CDMO Capability: A Driver for Combination Product Optimization Discover how green propellants are paving the way for eco-friendly inhalers.
Oxbryta Clinical Trial Deaths Led to Recall Reports have suggested that Pfizer’s decision to recall and withdraw Oxbryta from the
Optimizing Imaging Response Criteria for Improved Outcomes in Oncology Clinical Trials Enhance clinical trial outcomes by customizing radiologic assessment criteria
Author: Harietta Eleftherochorinou, Vice President, AI Strategy and Operations, IQVIA We are entering a new era of artificial intelligence (AI) in
According to her lawsuit, Holcomb was diagnosed with breast cancer in June 2021, and underwent a lumpectomy and partial mastectomy
Unlocking Global Access to Liquid Biopsy-a Panel Discussion See how Guardant Health is increasing access to in-country liquid biopsy testing